Non-musculoskeletal benefits of vitamin D

Journal of Steroid Biochemistry and Molecular Biology

Volumn 175, Issue , 2018, Pages 60-81

  Wimalawansa, Sunil J ^a  

^a Cardio Metabolic Institute   (United States)

Author keywords

1,25(OH)2D; 25(OH)D; Cardiovascular hypertension; Complications; Falls; Fractures; Morbidity and mortality; Premature death; vitamin D receptor

Indexed keywords

VITAMIN D; VITAMIN D RECEPTOR; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D;

AGE RELATED MACULAR DEGENERATION; ALL CAUSE MORTALITY; ALZHEIMER DISEASE; ANALGESIA; AUTOIMMUNE DISEASE; BLOOD PRESSURE REGULATION; BONE TISSUE; CANCER INCIDENCE; CARDIAC MUSCLE CELL; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; COGNITION; COMORBIDITY; DEMENTIA; DENTAL HEALTH; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPHAGIA; ENDOTHELIUM CELL; EPILEPSY; EVOLUTION; GEOGRAPHY; HEART PROTECTION; HUMAN; HYPERTENSION; IMMUNITY; INFECTION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIGHT EXPOSURE; LUNG FUNCTION; MALIGNANT NEOPLASM; MENTAL FUNCTION; MORBIDITY; MORTALITY RATE; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOMALACIA; OVERACTIVE BLADDER; PHYSICAL ACTIVITY; PHYSIOLOGY; PRACTICE GUIDELINE; PREGNANCY; QUALITY OF LIFE; REVIEW; RICKETS; SARCOPENIA; SMOOTH MUSCLE CELL; SUNLIGHT; SURVIVAL RATE; THERAPY EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC COMPLICATION; ETHNOLOGY; INCIDENCE; MORTALITY; OSTEOPOROSIS; SURVIVAL ANALYSIS;

AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CONTINENTAL POPULATION GROUPS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; INCIDENCE; NEURODEGENERATIVE DISEASES; OSTEOPOROSIS; SARCOPENIA; SURVIVAL ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84992319361     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.09.016     Document Type: Review

References (428)

1. Wimalawansa, S.J., Vitamin D: Everything You Need to Know. 2012, Karunaratne & Sons, Homagama, Sri Lanka 978-955-9098-94-2.
2. Wahl, D.A., Cooper, C., Ebeling, P.R., Eggersdorfer, M., Hilger, J., Hoffmann, K., et al. A global representation of vitamin D status in healthy populations. Arch. Osteoporos. 7 (2012), 155–172.
3. Webb, A.R., Engelsen, O., Ultraviolet exposure scenarios: risks of erythema from recommendations on cutaneous vitamin D synthesis. Adv. Exp. Med. Biol. 810 (2014), 406–422.
4. Grant, W.B., Strange, R.C., Garland, C.F., Sunshine is good medicine: the health benefits of ultraviolet-B induced vitamin D production. J. Cosmet. Dermatol. 2:2 (2003), 86–98.
5. van Schoor, N.M., Lips, P., Worldwide Vitamin D status. Best Pract. Res. Clin. Endocrinol. Metab. 25:4 (2011), 671–680.
6. Eggemoen, A.R., Knutsen, K.V., Dalen, I., Jenum, A.K., Vitamin D status in recently arrived immigrants from Africa and Asia: a cross-sectional study from Norway of children, adolescents and adults. BMJ Open, 3(10), 2013, e003293.
7. Garland, C.F., Gorham, E.D., Mohr, S.B., Garland, F.C., Vitamin D for cancer prevention: global perspective. Ann. Epidemiol. 19:7 (2009), 468–483.
8. Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., Dawson-Hughes, B., Eisman, J.A., et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20:11 (2009), 1807–1820.
9. Wimalawansa, S.J., Vitamin D in the new millennium. Curr. Osteoporos. Rep. 10:1 (2012), 4–15.
10. Grant, W.B., Wimalawansa, S.J., Holick, M.F., Vitamin D supplements and reasonable solar UVB should be recommended to prevent escalating incidence of chronic diseases. Br. Med. J., 350, 2015, h321.
11. Holick, M.F., High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 81:3 (2006), 353–373.
12. Colapinto, C.K., Rossiter, M., Khan, M.K., Kirk, S.F., Veugelers, P.J., Obesity, lifestyle and socio-economic determinants of vitamin D intake: a population-based study of Canadian children. Can. J. Public Health 105:6 (2014), e418–24.
13. Holick, M.F., Vitamin D and bone health. J. Nutr. 126:4 Suppl (1996), 1159S–1164S.
14. Lu, Z., Chen, T.C., Zhang, A., Persons, K.S., Kohn, N., Berkowitz, R., et al. An evaluation of the vitamin D3 content in fish: is the Vitamin D content adequate to satisfy the dietary requirement for Vitamin D?. J. Steroid Biochem. Mol. Biol. 103:3–5 (2007), 642–644.
15. Hedlund, L., Brembeck, P., Olausson, H., Determinants of vitamin D status in fair-skinned women of childbearing age at northern latitudes. PLoS One, 8(4), 2013, e60864.
16. Touma, Z., Eder, L., Zisman, D., Feld, J., Chandran, V., Rosen, C.F., et al. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care Res. (Hoboken) 63:10 (2011), 1440–1447.
17. Wimalawansa, S.J., Vitamin D: biology, physiology, and pathology. J. Diabetes Treat., 2016 (in press).
18. Lips, P., Worldwide status of vitamin D nutrition. J. Steroid Biochem. Mol. Biol. 121:1–2 (2010), 297–300.
19. Chaplin, G., Jablonski, N.G., Vitamin D and the evolution of human depigmentation. Am. J. Phys. Anthropol. 139:4 (2009), 451–461.
20. Durazo-Arvizu, R.A., Camacho, P., Bovet, P., Forrester, T., Lambert, E.V., Plange-Rhule, J., et al. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am. J. Clin. Nutr. 100:3 (2014), 908–914.
21. Rockell, J.E., Green, T.J., Skeaff, C.M., Whiting, S.J., Taylor, R.W., Williams, S.M., et al. Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5–14 y. J. Nutr. 135:11 (2005), 2602–2608.
22. Bodnar, L.M., Catov, J.M., Simhan, H.N., Holick, M.F., Powers, R.W., Roberts, J.M., Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 92:9 (2007), 3517–3522.
23. Bodnar, L.M., Catov, J.M., Zmuda, J.M., Cooper, M.E., Parrott, M.S., Roberts, J.M., et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J. Nutr. 140:5 (2010), 999–1006.
24. Lewis, S., Lucas, R.M., Halliday, J., Ponsonby, A.L., Vitamin D deficiency and pregnancy: from preconception to birth. Mol. Nutr. Food Res. 54:8 (2010), 1092–1102.
25. Hakim, O.A., Hart, K., McCabe, P., Berry, J., Francesca, R., Rhodes, L.E., et al. Vitamin D production in UK Caucasian and South Asian women following UVR exposure. J. Steroid Biochem. Mol. Biol., 2016.
26. Rojansky, N., Brzezinski, A., Schenker, J.G., Seasonality in human reproduction: an update. Hum. Reprod. 7:6 (1992), 735–745.
27. Grant, W.B., Garland, C.F., The vitamin D revolution. Mol. Nutr. Food Res., 54(8), 2010, 1053.
28. Parikh, G., Varadinova, M., Suwandhi, P., Araki, T., Rosenwaks, Z., Poretsky, L., et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm. Metab. Res. 42:10 (2010), 754–757.
29. Al-Daghri, N.M., Al-Saleh, Y., Khan, N., Sabico, S., Aljohani, N., Alfawaz, H., et al. Sun exposure, skin color and vitamin D status in Arab children and adults. J. Steroid Biochem. Mol. Biol., 2016.
30. Buyukuslu, N., Esin, K., Hizli, H., Sunal, N., Yigit, P., Garipagaoglu, M., Clothing preference affects vitamin D status of young women. Nutr. Res. 34:8 (2014), 688–693.
31. Terushkin, V., Bender, A., Psaty, E.L., Engelsen, O., Wang, S.Q., Halpern, A.C., Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes. J. Am. Acad. Dermatol. 62:6 (2010), e1–e9 929.
32. Alpert, P.T., Shaikh, U., The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems. Biol. Res. Nurs. 9:2 (2007), 117–129.
33. Breslin, L.C., Magee, P.J., Wallace, J.M., McSorley, E.M., An evaluation of vitamin D status in individuals with systemic lupus erythematosus. Proc. Nutr. Soc., 2011, 1–9.
34. Godar, D.E., Pope, S.J., Grant, W.B., Holick, M.F., Solar, U.V., Doses of young americans and vitamin D3 production. Environ. Health Perspect., 2011.
35. Matsuoka, L.Y., Ide, L., Wortsman, J., MacLaughlin, J.A., Holick, M.F., Sunscreens suppress cutaneous vitamin D3 synthesis. J. Clin. Endocrinol. Metab. 64:6 (1987), 1165–1168.
36. Osterwalder, U., Herzog, B., Sun protection factors: world wide confusion. Br. J. Dermatol. 161:Suppl 3 (2009), 13–24.
37. Stechschulte, S.A., Kirsner, R.S., Federman, D.G., Sunscreens for non-dermatologists: what you should know when counseling patients. Postgrad. Med. 123:4 (2011), 160–167.
38. Holick, M.F., Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need. Adv. Exp. Med. Biol. 624 (2008), 1–15.
39. Harju, E., Sotaniemi, E., Puranen, J., Lahti, R., High incidence of low serum vitamin D concentration in patients with hip fracture. Arch. Orthop. Trauma Surg. 103:6 (1985), 408–416.
40. Hollis, B.W., Wagner, C.L., Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 98:12 (2013), 4619–4628.
41. Wimalawansa, S.J., Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, type 2 diabetes, and future metabolic complications. J. Diabetes Metab. Disord. Control 3:1 (2016), 1–10.
42. Heaney, R.P., Dowell, M.S., Hale, C.A., Bendich, A., Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J. Am. Coll. Nutr. 22:2 (2003), 142–146.
43. Steingrimsdottir, L., Gunnarsson, O., Indridason, O.S., Franzson, L., Sigurdsson, G., Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:18 (2005), 2336–2341.
44. Khan, H., Kunutsor, S., Franco, O.H., Chowdhury, R., Vitamin D type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc. Nutr. Soc. 72:1 (2013), 89–97.
45. Lappe, J.M., Heaney, R.P., Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinology 4:2 (2012), 95–100.
46. Garland, C.F., Garland, F.C., Gorham, E.D., Lipkin, M., Newmark, H., Mohr, S.B., et al. The role of vitamin D in cancer prevention. Am. J. Public Health 96:2 (2006), 252–261.
47. Giovannucci, E., Liu, Y., Willett, W.C., Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol. Biomarkers Prev. 15:12 (2006), 2467–2472.
48. Gross, M.D., Vitamin D and calcium in the prevention of prostate and colon cancer: new approaches for the identification of needs. J. Nutr. 135:2 (2005), 326–331.
49. Vieth, R., Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 89–90:1–5 (2004), 575–579.
50. George, P.S., Pearson, E.R., Witham, M.D., Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet. Med. 29:8 (2012), e142–50.
51. Manousopoulou, A., Al-Daghri, N.M., Garbis, S.D., Chrousos, G.P., Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. Eur. J. Clin. Invest. 45:10 (2015), 1113–1126.
52. Pilz, S., Kienreich, K., Rutters, F., de Jongh, R., van Ballegooijen, A.J., Grubler, M., et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr. Diab. Rep. 13:2 (2013), 261–270.
53. Sung, C.C., Liao, M.T., Lu, K.C., Wu, C.C., Role of vitamin D in insulin resistance. J. Biomed. Biotechnol., 2012, 2012, 634195.
54. Takiishi, T., Gysemans, C., Bouillon, R., Mathieu, C., Vitamin D and diabetes. Rheum. Dis. Clin. North Am. 38:1 (2012), 179–206.
55. Luxwolda, M.F., Kuipers, R.S., Kema, I.P., van der Veer, E., Dijck-Brouwer, D.A.J., Muskiet, F.A.J., Vitamin D status indicators in indigenous populations in East Africa. Eur. J. Nutr. 52:3 (2013), 1115–1125.
56. Weishaar, T., Vergili, J.M., Vitamin D status is a biological determinant of health disparities. J. Acad. Nutr. Diet 113:5 (2013), 643–651.
57. Ginde, A.A., Liu, M.C., Camargo, C.A. Jr., Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch. Intern. Med. 169:6 (2009), 626–632.
58. Melamed, M.L., Michos, E.D., Post, W., Astor, B., 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168:15 (2008), 1629–1637.
59. Adler, N.E., Boyce, T., Chesney, M.A., Cohen, S., Folkman, S., Kahn, R.L., et al. Socioeconomic status and health: the challenge of the gradient. Am. Psychol. 49:1 (1994), 15–24.
60. Weishaar, T., Vergili, J.M., Vitamin D status is a biological determinant of health disparities. J Acad. Nutr. Diet. 113:5 (2013), 643–651.
61. Meier, C., Woitge, H.W., Witte, K., Lemmer, B., Seibel, M.J., Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J. Bone Miner. Res. 19:8 (2004), 1221–1230.
62. Suzuki, T., Kwon, J., Kim, H., Shimada, H., Yoshida, Y., Iwasa, H., et al. Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly. J. Bone Miner. Res. 23:8 (2008), 1309–1317.
63. Choi, H.S., Kim, K.A., Lim, C.Y., Rhee, S.Y., Hwang, Y.C., Kim, K.M., et al. Low serum vitamin D is associated with high risk of diabetes in Korean adults. J. Nutr. 141:8 (2011), 1524–1528.
64. Gupta, A.K., Brashear, M.M., Johnson, W.D., Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care 34:3 (2011), 658–660.
65. Munger, K.L., Zhang, S.M., O'Reilly, E., Hernan, M.A., Olek, M.J., Willett, W.C., et al. Vitamin, D., intake and incidence of multiple sclerosis. Neurology 62:1 (2004), 60–65.
66. Merlino, L.A., Curtis, J., Mikuls, T.R., Cerhan, J.R., Criswell, L.A., Saag, K.G., Vitamin, D., intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 50:1 (2004), 72–77.
67. McCullough, M.L., Robertson, A.S., Rodriguez, C., Jacobs, E.J., Chao, A., Carolyn, J., et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes Control 14:1 (2003), 1–12.
68. Cosenso-Martin, L.N., Vilela-Martin, J.F., Is there an association between vitamin D and hypertension?. Recent Pat. Cardiovasc. Drug Discov. 6:2 (2011), 140–147.
69. Altieri, B., Grant, W.B., Casa, S.D., Orio, F., Pontecorvi, A., Colao, A., et al. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer. Crit. Rev. Food Sci. Nutr., 2016, 0.
70. Mark, B.L., Carson, J.A., Vitamin D and autoimmune disease–implications for practice from the multiple sclerosis literature. J. Am. Diet. Assoc. 106:3 (2006), 418–424.
71. Ponsonby, A.L., Lucas, R.M., van der Mei, I.A., UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem. Photobiol. 81:6 (2005), 1267–1275.
72. Chiu, K.C., Chu, A., Go, V.L., Saad, M.F., Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79:5 (2004), 820–825.
73. Hamed, E.A., Abu Faddan, N.H., Adb Elhafeez, H.A., Sayed, D., Parathormone – 25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr. Diabetes 12:6 (2011), 536–546.
74. Feskanich, D., Willett, W.C., Colditz, G.A., Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J. Clin. Nutr. 77:2 (2003), 504–511.
75. Lieberman, D.A., Prindiville, S., Weiss, D.G., Willett, W., Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 290:22 (2003), 2959–2967.
76. Slattery, M.L., Neuhausen, S.L., Hoffman, M., Caan, B., Curtin, K., Ma, K.N., et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int. J. Cancer 111:5 (2004), 750–756.
77. Rummens, K., van Cromphaut, S.J., Carmeliet, G., van Herck, E., van Bree, R., Stockmans, I., et al. Pregnancy in mice lacking the vitamin D receptor: normal maternal skeletal response, but fetal hypomineralization rescued by maternal calcium supplementation. Pediatr. Res. 54:4 (2003), 466–473.
78. Koo, W.W., Tsang, R., Bone mineralization in infants. Prog. Food Nutr. Sci. 8:3–4 (1984), 229–302.
79. Khazai, N., Judd, S.E., Tangpricha, V., Calcium and vitamin D: skeletal and extraskeletal health. Curr. Rheumatol. Rep. 10:2 (2008), 110–117.
80. Elmadfa, I., Meyer, A.L., Vitamins for the first 1000 days: preparing for life. Int. J. Vitam. Nutr. Res. 82:5 (2012), 342–347.
81. Genuis, S.J., Maternal and pediatric health outcomes: in relation to gestational Vitamin D sufficiency. Obstet. Gynecol. Int., 2015, 2015, 501829.
82. Kovacs, C.S., Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am. J. Clin. Nutr. 88:2 (2008), 520S–528S.
83. Kramer, C.K., Ye, C., Swaminathan, B., Hanley, A.J., Connelly, P.W., Sermer, M., et al. The persistence of maternal vitamin D deficiency and insufficiency during pregnancy and lactation irrespective of season and supplementation. Clin. Endocrinol. (Oxf.) 84:5 (2016), 680–686.
84. Strom, M., Halldorsson, T.I., Hansen, S., Granstrom, C., Maslova, E., Petersen, S.B., et al. Vitamin D measured in maternal serum and offspring neurodevelopmental outcomes: a prospective study with long-term follow-up. Ann. Nutr. Metab. 64:3–4 (2014), 254–261.
85. Pfeifer, M., Begerow, B., Minne, H.W., Vitamin D and muscle function. Osteoporos. Int. 13:3 (2002), 187–194.
86. Boudville, N., Inderjeeth, C., Elder, G.J., Glendenning, P., Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end stage renal failure. Clin. Endocrinol. (Oxf.), 2010.
87. Mosekilde, L., Vitamin D and the elderly. Clin. Endocrinol. (Oxf.) 62:3 (2005), 265–281.
88. Nashimoto, M., Nakamura, K., Matsuyama, S., Hatakeyama, M., Yamamoto, M., Hypovitaminosis D and hyperparathyroidism in physically inactive elderly Japanese living in nursing homes: relationship with age, sunlight exposure and activities of daily living. Aging Clin. Exp. Res. 14:1 (2002), 5–12.
89. Vanlint, S., Nugent, M., Durvasula, S., Vitamin D and people with intellectual disability. Aust. Fam. Phys. 37:5 (2008), 348–351.
90. Jolliffe, D.A., Hanifa, Y., Witt, K.D., Venton, T.R., Rowe, M., Timms, P.M., et al. Environmental and genetic determinants of vitamin D status among older adults in London, UK. J. Steroid Biochem. Mol. Biol., 2016.
91. Ng, K.Y., Ma, M.T., Leung, K.K., Leung, P.S., Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Stem Cell Rev. 7:1 (2011), 53–63.
92. Moyad, M.A., The potential benefits of dietary and/or supplemental calcium and vitamin D. Urol. Oncol. 21:5 (2003), 384–391.
93. Kilpinen-Loisa, P., Nenonen, H., Pihko, H., Makitie, O., High-dose vitamin D supplementation in children with cerebral palsy or neuromuscular disorder. Neuropediatrics 38:4 (2007), 167–172.
94. Binkley, N., Is vitamin D the fountain of youth?. Endocr. Pract. 15:6 (2009), 590–596.
95. Norman, A.W., Bouillon, R., Whiting, S.J., Vieth, R., Lips, P., 13th Workshop consensus for vitamin D nutritional guidelines. J. Steroid Biochem. Mol. Biol. 103:3–5 (2007), 204–205.
96. Binkley, N., Does low vitamin D status contribute to age-related morbidity?. J. Bone Miner. Res. 22:Suppl 2 (2007), V55–V58.
97. Holick, M.F., Vitamin D: a D-lightful health perspective. Nutr. Rev. 66:10 Suppl 2 (2008), S182–S194.
98. Bischoff-Ferrari, H.A., Dietrich, T., Orav, E.J., Hu, F.B., Zhang, Y., Karlson, E.W., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am. J. Clin. Nutr. 80:3 (2004), 752–758.
99. Bruce, D.G., St John, A., Nicklason, F., Goldswain, P.R., Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency. J. Am. Geriatr. Soc. 47:3 (1999), 354–359.
100. Bischoff-Ferrari, H.A., Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv. Exp. Med. Biol. 624 (2008), 55–71.
101. Snijder, M.B., van Schoor, N.M., Pluijm, S.M., van Dam, R.M., Visser, M., Lips, P., Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J. Clin. Endocrinol. Metab. 91:8 (2006), 2980–2985.
102. Institute of Medicine, 2010. Pages. Accessed at Food and Nutrition Board at http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx.
103. Perez-Lopez, F.R., Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 58:2 (2007), 117–137.
104. Whiting, S.J., Calvo, M.S., Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J. Nutr. 135:2 (2005), 304–309.
105. Weyland, P.G., Grant, W.B., Howie-Esquivel, J., Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality. Nutrients 6:9 (2014), 3403–3430.
106. Hisatake, J., O'Kelly, J., Uskokovic, M.R., Tomoyasu, S., Koeffler, H.P., Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 97:8 (2001), 2427–2433.
107. Morales-Tirado, V., Wichlan, D.G., Leimig, T.E., Street, S.E., Kasow, K.A., Riberdy, J.M., 1alpha,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3. Clin. Immunol. 138:2 (2011), 212–221.
108. Porojnicu, A.C., Dahlback, A., Moan, J., Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv. Exp. Med. Biol. 624 (2008), 43–54.
109. Porojnicu, A.C., Lagunova, Z., Robsahm, T.E., Berg, J.P., Dahlback, A., Moan, J., Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res. Treat. 102:3 (2007), 323–328.
110. Garland, C.F., Garland, F.C., Gorham, E.D., Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann. N. Y. Acad. Sci. 889 (1999), 107–119.
111. O. Health Quality, Clinical utility of vitamin d testing: an evidence-based analysis. Ont. Health Technol. Assess. Ser. 10:2 (2010), 1–93.
112. Lagunova, Z., Porojnicu, A.C., Dahlback, A., Berg, J.P., Beer, T.M., Moan, J., Prostate cancer survival is dependent on season of diagnosis. Prostate 67:12 (2007), 1362–1370.
113. Petersen, R.A., Damsgaard, C.T., Dalskov, S.M., Sorensen, L.B., Hjorth, M.F., Ritz, C., et al. Vitamin D status and its determinants during autumn in children at northern latitudes: a cross-sectional analysis from the optimal well-being, development and health for Danish children through a healthy New Nordic Diet (OPUS) School Meal Study. Br. J. Nutr. 115:2 (2016), 239–250.
114. Huotari, A., Herzig, K.H., Vitamin D and living in northern latitudes-an endemic risk area for vitamin D deficiency. Int. J. Circumpolar Health 67:2–3 (2008), 164–178.
115. Kimlin, M.G., Downs, N.J., Parisi, A.V., Comparison of human facial UV exposure at high and low latitudes and the potential impact on dermal vitamin D production. Photochem. Photobiol. Sci. 2:4 (2003), 370–375.
116. Malloy, P.J., Feldman, D., Genetic disorders and defects in vitamin D action. Rheum. Dis. Clin. North Am. 38:1 (2012), 93–106.
117. Pike, J.W., Meyer, M.B., The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum. Dis. Clin. North Am. 38:1 (2012), 13–27.
118. Muindi, J.R., Adjei, A.A., Wu, Z.R., Olson, I., Huang, H., Groman, A., et al. Serum vitamin d metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the Vitamin D genes. Horm. Cancer, 2013.
119. Fuhrman, B.J., Freedman, D.M., Bhatti, P., Doody, M.M., Fu, Y.P., Chang, S.C., et al. Sunlight, polymorphisms of Vitamin D-related genes and risk of Breast cancer. Anticancer Res. 33:2 (2013), 543–551.
120. Giovannucci, E., Epidemiology of vitamin d and colorectal cancer. Anticancer Agents Med. Chem. 13:1 (2013), 11–19.
121. Pande, M., Thompson, P.A., Do, K.A., Sahin, A.A., Amos, C.I., Frazier, M.L., et al. Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis 34:3 (2013), 587–594.
122. Binkley, N., Ramamurthy, R., Krueger, D., Low vitamin D status: definition, prevalence, consequences, and correction. Rheum. Dis. Clin. North Am. 38:1 (2012), 45–59.
123. Grant, W.B., 25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. Anticancer Res. 35:2 (2015), 1153–1160.
124. Lappe, J.M., Travers-Gustafson, D., Davies, K.M., Recker, R.R., Heaney, R.P., Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85:6 (2007), 1586–1591.
125. Moukayed, M., Grant, W.B., Molecular link between vitamin D and cancer prevention. Nutrients 5:10 (2013), 3993–4021.
126. Ferronato, M.J., Alonso, E.N., Gandini, N.A., Fermento, M.E., Villegas, M.E., Quevedo, M.A., et al. The UVB1 Vitamin D analogue inhibits colorectal carcinoma progression. J. Steroid Biochem. Mol. Biol. 163 (2016), 193–205.
127. Edvardsen, K., Veierod, M.B., Brustad, M., Braaten, T., Engelsen, O., Lund, E., Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk. Int. J. Cancer 128:6 (2011), 1425–1433.
128. Engel, P., Fagherazzi, G., Mesrine, S., Boutron-Ruault, M.C., Clavel-Chapelon, F., Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N Cohort. Cancer Epidemiol. Biomarkers Prev. 20:1 (2011), 187–198.
129. Grant, W.B., Juzeniene, A., Lagunova, Z., Porojnicu, A.C., Moan, J.E., Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer. Int. J. Cancer 128:9 (2011), 2249–2250.
130. Grant, W.B., Garland, C.F., Evidence supporting the role of vitamin D in reducing the risk of cancer. J. Intern. Med. 252:2 (2002), 178–179 (author reply 9–80).
131. Grant, W.B., An estimate of premature cancer mortality in the U.S due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:6 (2002), 1867–1875.
132. Baron, J.A., Beach, M., Mandel, J.S., van Stolk, R.U., Haile, R.W., Sandler, R.S., et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N. Engl. J. Med. 340:2 (1999), 101–107.
133. Giovannucci, E., Liu, Y., Rimm, E.B., Hollis, B.W., Fuchs, C.S., Stampfer, M.J., et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl. Cancer Inst. 98:7 (2006), 451–459.
134. Lazzeroni, M., Serrano, D., Pilz, S., Gandini, S., Vitamin D supplementation and cancer: review of randomized controlled trials. Anticancer Agents Med. Chem. 13:1 (2013), 118–125.
135. Pilz, S., Editorial: vitamin d and cancer: current evidence and future perspective. Anticancer Agents Med. Chem. 13:1 (2013), 2–3.
136. Freedman, D.M., Looker, A.C., Chang, S.C., Graubard, B.I., Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst. 99:21 (2007), 1594–1602.
137. Grant, W.B., Weighing the evidence linking UVB irradiance, vitamin D, and cancer risk. Mayo Clin. Proc. 86:4 (2011), 362–363 (author reply 3).
138. Veldhuis, S., Wolbers, F., Brouckaert, O., Vermes, I., Franke, H.R., Cancer prevalence in osteoporotic women with low serum vitamin D levels. Menopause 18:3 (2011), 319–322.
139. Grant, W.B., The Institute of Medicine did not find the vitamin D-cancer link because it ignored UV-B dose studies. Public Health Nutr. 14:4 (2011), 745–746.
140. Davis, C.D., Milner, J.A., Nutrigenomics, vitamin D and cancer prevention. J Nutrigenet. Nutrigenom. 4:1 (2011), 1–11.
141. Grant, W.B., Sun exposure, vitamin D and cancer risk reduction (Letter to the Editor). Eur. J. Cancer 49 (2013), 2073 207–5.
142. Bergren, T., Heuberger, R., Vitamin D and breast cancer prevention: practical guidelines for clinicians. Nurs. Womens Health 14:5 (2010), 368–375.
143. Deeb, K.K., Trump, D.L., Johnson, C.S., Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 7:9 (2007), 684–700.
144. Zhang, X., Giovannucci, E., Calcium, vitamin D and colorectal cancer chemoprevention. Best Pract. Res. Clin. Gastroenterol. 25:4–5 (2011), 485–494.
145. Shao, T., Klein, P., Grossbard, M.L., Vitamin D and breast cancer. Oncologist 17:1 (2012), 36–45.
146. Crew, K.D., Gammon, M.D., Steck, S.E., Hershman, D.L., Cremers, S., Dworakowski, E., et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev. Res. (Phila.) 2:6 (2009), 598–604.
147. Helzlsouer, K.J., Overview of the cohort consortium Vitamin D pooling project of rarer cancers. Am. J. Epidemiol. 172:1 (2010), 4–9.
148. Welsh, J., Cellular and molecular effects of vitamin D on carcinogenesis. Arch. Biochem. Biophys., 2011.
149. Cauley, J.A., Chlebowski, R.T., Wactawski-Wende, J., Robbins, J.A., Rodabough, R.J., Chen, Z., et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J. Womens Health (Larchmt.) 22:11 (2013), 915–929.
150. Sperati, F., Vici, P., Maugeri-Sacca, M., Stranges, S., Santesso, N., Mariani, L., et al. Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One, 8(7), 2013, e69269.
151. Lindsey, A.M., Gross, G., Twiss, J., Waltman, N., Ott, C., Moore, T.E., Postmenopausal survivors of breast cancer at risk for osteoporosis: nutritional intake and body size. Cancer Nurs. 25:1 (2002), 50–56.
152. Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R.F., et al. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol. Assess. 14:32 (2010), 1–206.
153. Huncharek, M., Muscat, J., Kupelnick, B., Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr. Cancer 61:1 (2009), 47–69.
154. Grant, W.B., Roles of solar UVB and Vitamin D in reducing cancer risk and increasing survival. Anticancer Res. 36:3 (2016), 1357–1370.
155. Waterhouse, M., Risch, H.A., Bosetti, C., Anderson, K.E., Petersen, G.M., Bamlet, W.R., et al. Vitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortium. Ann. Oncol. 26:8 (2015), 1776–1783.
156. Grant, W.B., How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermatoendocrinology 1:1 (2009), 17–24.
157. Alkhenizan, A., Hafez, K., The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Ann. Saudi Med. 27:6 (2007), 409–414.
158. Grant, W.B., An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int. J. Cancer 120:5 (2007), 1123–1128.
159. van Leeuwen, M.T., Turner, J.J., Falster, M.O., Meagher, N.S., Joske, D.J., Grulich, A.E., et al. Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure. Int. J. Cancer 133:4 (2013), 944–951.
160. Bertrand, K.A., Chang, E.T., Abel, G.A., Zhang, S.M., Spiegelman, D., Qureshi, A.A., et al. Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study. Cancer Causes Control 22:12 (2011), 1731–1741.
161. Gallicchio, L., Helzlsouer, K.J., Chow, W.H., Freedman, D.M., Hankinson, S.E., Hartge, P., et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the cohort consortium Vitamin D pooling project of rarer cancers. Am. J. Epidemiol. 172:1 (2010), 10–20.
162. Bolland, M.J., Grey, A., Gamble, G.D., Reid, I.R., Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr. 94:4 (2011), 1144–1149.
163. Fleet, J.C., DeSmet, M., Johnson, R., Li, Y., Vitamin D and cancer: a review of molecular mechanisms. Biochem. J 441:1 (2012), 61–76.
164. Vashi, P.G., Trukova, K., Lammersfeld, C.A., Braun, D.P., Gupta, D., Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr. J., 9, 2010, 60.
165. Aguirre, M., Manzano, N., Salas, Y., Angel, M., Diaz-Couselo, F.A., Zylberman, M., Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina. Arch. Osteoporos., 11, 2016, 4.
166. Vashi, P.G., Lammersfeld, C.A., Braun, D.P., Gupta, D., Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr. J., 10, 2011, 51.
167. Holick, M.F., Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin. J. Am. Soc. Nephrol. 3:5 (2008), 1548–1554.
168. Pourshahidi, L.K., Vitamin D and obesity: current perspectives and future directions. Proc. Nutr. Soc. 74:2 (2015), 115–124.
169. Siegel, R., Ward, E., Brawley, O., Jemal, A., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA. Cancer J. Clin. 61:4 (2011), 212–236.
170. Trivedi, D.P., Doll, R., Khaw, K.T., Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ, 326(7387), 2003, 469.
171. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96:7 (2011), 1911–1930.
172. Semba, R.D., Houston, D.K., Bandinelli, S., Sun, K., Cherubini, A., Cappola, A.R., et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 64:2 (2010), 203–209.
173. Ginde, A.A., Scragg, R., Schwartz, R.S., Camargo, C.A. Jr., Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 57:9 (2009), 1595–1603.
174. Dobnig, H., Pilz, S., Scharnagl, H., Renner, W., Seelhorst, U., Wellnitz, B., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168:12 (2008), 1340–1349.
175. Bjelakovic, G., Gluud, L.L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R.G., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev., 7, 2011, CD007470.
176. Grant, W.B., An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur. J. Clin. Nutr. 65:9 (2011), 1016–1026.
177. Parker, J.H.O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N.B., Clarke, A., Franco, O.H., Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65 (2010), 225–236.
178. Chen, Y., Kong, J., Sun, T., Li, G., Szeto, F.L., Liu, W., et al. 1,25-Dihydroxyvitamin D(3) suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-kappaB activation. Arch. Biochem. Biophys. 507:2 (2011), 241–247.
179. Venkatesh, B., Nair, P., Hypovitaminosis D and morbidity in critical illness: is there proof beyond reasonable doubt?. Crit. Care, 18(3), 2014, 138.
180. Timms, P.M., Mannan, N., Hitman, G.A., Noonan, K., Mills, P.G., Syndercombe-Court, D., et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM 95:12 (2002), 787–796.
181. Li, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q., Cao, L.P., 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110:2 (2002), 229–238.
182. Braun, T.R., Been, L.F., Blackett, P.R., Sanghera, D.K., Vitamin D deficiency and cardio-metabolic risk in a north indian community with highly prevalent type 2 diabetes. J. Diabetes Metab., 2012, 3.
183. Anderson, J.L., May, H.T., Horne, B.D., Bair, T.L., Hall, N.L., Carlquist, J.F., Lappé, D.L., Muhlestein, J.B., Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106 (2010), 963–968.
184. Somjen, D., Weisman, Y., Kohen, F., Gayer, B., Limor, R., Sharon, O., et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111:13 (2005), 1666–1671.
185. Margolis, K.L., Ray, R.M., Van Horn, L., Manson, J.E., Allison, M.A., Black, H.R., et al. Effect of calcium and vitamin D supplementation on blood pressure: the women's health initiative randomized trial. Hypertension 52:5 (2008), 847–855.
186. Parker, J., Hashmi, O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N.B., et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65:3 (2010), 225–236.
187. Pilz, S., Kienreich, K., Tomaschitz, A., Ritz, E., Lerchbaum, E., Obermayer-Pietsch, B., et al. Vitamin d and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med. Chem. 13:1 (2013), 107–117.
188. McCarty, M.F., Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med. Hypotheses 72:6 (2009), 647–651.
189. Kelishadi, R., Farajzadegan, Z., Bahreynian, M., Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int. J. Food Sci. Nutr. 65:4 (2014), 404–410.
190. Lach, K., Krajewski-Siuda, K., Vitamin D3 in prevention of diseases in adults-a systematic review. Wiad. Lek. 63:4 (2010), 316–330.
191. Heravifard, S., Neyestani, T.R., Nikooyeh, B., Alavi-Majd, H., Houshiarrad, A., Kalayi, A., et al. Regular consumption of both vitamin D- and calcium- and vitamin D-fortified yogurt drink is equally accompanied by lowered blood lipoprotein (a) and elevated apoprotein A1 in subjects with type 2 diabetes: a randomized clinical trial. J. Am. Coll. Nutr. 32:1 (2013), 26–30.
192. Yilmaz, O., Olgun, H., Ciftel, M., Kilic, O., Kartal, I., Iskenderoglu, N.Y., et al. Dilated cardiomyopathy secondary to rickets-related hypocalcaemia: eight case reports and a review of the literature. Cardiol. Young 25:2 (2015), 261–266.
193. Wang, X.F., Deng, X.L., Wang, N.P., Roles of vitamin D in cardiovascular diseases. Sheng Li Ke Xue Jin Zhan 44:3 (2013), 223–226.
194. Nsengiyumva, V., Fernando, M.E., Moxon, J.V., Krishna, S.M., Pinchbeck, J., Omer, S.M., et al. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: a meta-analysis of observational studies. Atherosclerosis 243:2 (2015), 645–651.
195. Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:9736 (2010), 180–188.
196. Cantorna, M.T., Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 92:1 (2006), 60–64.
197. Thomasset, M., Vitamin D and the immune system. Pathol. Biol. (Paris) 42:2 (1994), 163–172.
198. Bikle, D.D., Vitamin D and the immune system: role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens. 17:4 (2008), 348–352.
199. Lin, R., White, J.H., The pleiotropic actions of vitamin D. Bioessays 26:1 (2004), 21–28.
200. Pani, M.A., Regulla, K., Segni, M., Krause, M., Hofmann, S., Hufner, M., et al. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Eur. J. Endocrinol. 146:6 (2002), 777–781.
201. LaCroix, A.Z., Kotchen, J., Anderson, G., Brzyski, R., Cauley, J.A., Cummings, S.R., et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J. Gerontol. A. Biol. Sci. Med. Sci. 64:5 (2009), 559–567.
202. Horrobin, D.F., Manku, M.S., Oka, M., Morgan, R.O., Cunnane, S.C., Ally, A.I., et al. The nutritional regulation of T lymphocyte function. Med. Hypotheses 5:9 (1979), 969–985.
203. McCarty, M.F., Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists. Med. Hypotheses 57:2 (2001), 258–275.
204. Hamzaoui, K., Ben Dhifallah, I., Karray, E., Sassi, F.H., Hamzaoui, A., Vitamin D modulates peripheral immunity in patients with Behcet's disease. Clin. Exp. Rheumatol. 28:4 Suppl 60 (2010), S50–S57.
205. Hock, A.D., Review: Vitamin D3 deficiency results in dysfunctions of immunity with severe fatigue and depression in a variety of diseases. In Vivo 28:1 (2014), 133–145.
206. Mascitelli, L., Pezzetta, F., Goldstein, M.R., Inflammatory bowel disease and the vitamin D endocrine system. Intern. Med. J. 41:4 (2011), 369–370.
207. Raman, M., Milestone, A.N., Walters, J.R., Hart, A.L., Ghosh, S., Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Ther. Adv. Gastroenterol. 4:1 (2011), 49–62.
208. Ardizzone, S., Cassinotti, A., Bevilacqua, M., Clerici, M., Porro, G.B., Vitamin D and inflammatory bowel disease. Vitam. Horm. 86 (2011), 367–377.
209. Levin, A.D., Wadhera, V., Leach, S.T., Woodhead, H.J., Lemberg, D.A., Czarina Mendoza-Cruz, A., et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig. Dis. Sci., 2011.
210. Attar, S.M., Vitamin D deficiency in rheumatoid arthritis Prevalence and association with disease activity in Western Saudi Arabia. Saudi Med. J. 33:5 (2012), 520–525.
211. Furuya, T., Hosoi, T., Tanaka, E., Nakajima, A., Taniguchi, A., Momohara, S., et al. Prevalence of and factors associated with vitamin D deficiency in 4,793 Japanese patients with rheumatoid arthritis. Clin. Rheumatol. 32:7 (2013), 1081–1087.
212. Ishikawa, L.L., Colavite, P.M., Fraga-Silva, T.F., Mimura, L.A., Franca, T.G., Zorzella-Pezavento, S.F., et al. Vitamin D deficiency and rheumatoid arthritis. Clin. Rev. Allergy Immunol., 2016.
213. Struglia, M., Stamerra, C.A., Di Giosia, P., Giorgini, P., Capanna, C., Grassi, D., et al. Vitamin, D., Deficiency and endothelial dysfunction in rheumatoid arthritis patients. J. Hypertens., 33(Suppl 1), 2015, e84.
214. Rossini, M., Maddali Bongi, S., La Montagna, G., Minisola, G., Malavolta, N., Bernini, L., et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther., 12(6), 2010, R216.
215. Liu, N., Kaplan, A.T., Low, J., Nguyen, L., Liu, G.Y., Equils, O., et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 80:3 (2009), 398–406.
216. Berry, D.J., Hesketh, K., Power, C., Hypponen, E., Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br. J. Nutr. 106:9 (2011), 1433–1440.
217. Anty, R., Anstee, Q.M., Gual, P., Tran, A., Prophylaxis of bacterial infections in cirrhosis: is an optimal 25-OH vitamin D level required?. J. Hepatol. 61:4 (2014), 965–966.
218. Grant, W.B., Goldstein, M., Mascitelli, L., Ample evidence exists from human studies that vitamin D reduces the risk of selected bacterial and viral infections. Exp Biol Med (Maywood) 235:12 (2010), 1395–1396 discussion 7.
219. Selvaraj, P., Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam. Horm. 86 (2011), 307–325.
220. Yamshchikov, A.V., Kurbatova, E.V., Kumari, M., Blumberg, H.M., Ziegler, T.R., Ray, S.M., Vitamin, D., et al. status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr. 92:3 (2010), 603–611.
221. Liu, P.T., Wheelwright, M., Teles, R., Komisopoulou, E., Edfeldt, K., Ferguson, B., et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat. Med. 18:2 (2012), 267–273.
222. Matzner, M., Al Samie, A.R., Winkler, H.M., Nemeth, J., Grasnek, A., Indra, A., et al. Low serum levels of cathelicidin LL-37 in leprosy. Acta Trop. 117:1 (2011), 56–59.
223. DeLuca, H.F., Cantorna, M.T., Vitamin D: its role and uses in immunology. FASEB J. 15:14 (2001), 2579–2585.
224. Gombart, A.F., The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 4:9 (2009), 1151–1165.
225. Jeffery, L.E., Wood, A.M., Qureshi, O.S., Hou, T.Z., Gardner, D., Briggs, Z., et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J. Immunol. 189:11 (2012), 5155–5164.
226. Banajeh, S.M., Nutritional rickets and vitamin D deficiency–association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr. Pulmonol. 44:12 (2009), 1207–1215.
227. Nnoaham, K.E., Clarke, A., Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 37:1 (2008), 113–139.
228. Ginde, A.A., Mansbach, J.M., Camargo, C.A. Jr., Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 169:4 (2009), 384–390.
229. Chesney, R.W., Vitamin D and The Magic Mountain: the anti-infectious role of the vitamin. J. Pediatr. 156:5 (2010), 698–703.
230. Lin, L., Yao, J., Chen, G., Lin, C., A severe H7N9 pneumonia with syndrome of inappropriate antidiuresis and vitamin D deficiency. Respir. Med. Case Rep. 12 (2014), 37–38.
231. Niederstrasser, J., Herr, C., Wolf, L., Lehr, C.M., Beisswenger, C., Bals, R., Vitamin D deficiency does not result in a breach of host defense in murine models of pneumonia. Infect. Immun., 2016.
232. Pletz, M.W., Terkamp, C., Schumacher, U., Rohde, G., Schutte, H., Welte, T., et al. Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir. Res., 15, 2014, 53.
233. Vuichard Gysin, D., Dao, D., Gysin, C.M., Lytvyn, L., Loeb, M., Effect of vitamin D3 supplementation on respiratory tract infections in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. PLoS One, 11(9), 2016, e0162996.
234. Judd, S.E., Raiser, S.N., Kumari, M., Tangpricha, V., 1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J. Steroid Biochem. Mol. Biol. 121:1–2 (2010), 445–447.
235. Nasri, H., Behradmanesh, S., Ahmadi, A., Rafieian-Kopaei, M., Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J. Nephropathol. 3:1 (2014), 29–33.
236. Daly, R.M., Nowson, C.A., Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men. Eur. J. Clin. Nutr. 63:8 (2009), 993–1000.
237. Wimalawansa, S.J., Antihypertensive effects of oral calcium supplementation may be mediated through the potent vasodilator CGRP. Am. J. Hypertens. 6:12 (1993), 996–1002.
238. Al Mheid, I., Patel, R.S., Tangpricha, V., Quyyumi, A.A., Vitamin D and cardiovacular disease: is the evidence solid?. Eur. Heart J. 34:483 (2013), 691–698.
239. Mheid e.a, I.A., Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J. Am. Coll. Cardiol. 58:2 (2011), 186–192.
240. Gepner, A.D., Ramamurthy, R., Krueger, D.C., Korcarz, C.E., Binkley, N., Stein, J.H., A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One, 7(5), 2012, e36617.
241. Halliday, T.M., Peterson, N.J., Thomas, J.J., Kleppinger, K., Hollis, B.W., Larson-Meyer, D.E., Vitamin D status relative to diet, lifestyle, injury, and illness in college athletes. Med. Sci. Sports Exerc. 43:2 (2011), 335–343.
242. Tangpricha, V., Turner, A., Spina, C., Decastro, S., Chen, T.C., Holick, M.F., Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am. J. Clin. Nutr. 80:6 (2004), 1645–1649.
243. Afzal, S., Bojesen, S.E., Nordestgaard, B.G., Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin. Chem. 59:2 (2013), 381–391.
244. Mitri, J., Muraru, M.D., Pittas, A.G., Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 65:9 (2011), 1005–1015.
245. Lee, D.M., Tajar, A., Pye, S.R., Boonen, S., Vanderschueren, D., Bouillon, R., et al. Association of hypogonadism with vitamin d status: the european male ageing study. Eur. J. Endocrinol. 166:1 (2012), 77–85.
246. Tepper, S., Shahar, D.R., Geva, D., Ish-Shalom, S., Differences in homeostatic model assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: a double-blind randomized controlled trial. Diabetes Obes. Metab. 18:6 (2016), 633–637.
247. Cheng, Q., Boucher, B.J., Leung, P.S., Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice. Diabetologia 56:3 (2013), 553–562.
248. Shab-Bidar, S., Neyestani, T.R., Djazayery, A., Vitamin D receptor Cdx-2-dependent response of central obesity to vitamin D intake in the subjects with type 2 diabetes: a randomised clinical trial. Br. J. Nutr. 114:9 (2015), 1375–1384.
249. Mathieu, C., Vitamin D and diabetes: where do we stand?. Diabetes Res. Clin. Pract. 108:2 (2015), 201–209.
250. Van Belle, T.L., Gysemans, C., Mathieu, C., Vitamin D and diabetes: the odd couple. Trends Endocrinol. Metab. 24:11 (2013), 561–568.
251. Zipitis, C., Akobeng, A.K., Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 93:6 (2008), 512–517.
252. Cannell, J.J., Grant, W.B., Holick, M.F., Vitamin D and inflammation. Dermatoendocrinology, 6(1), 2014, e983401.
253. Gonzalez-Molero, I., Rojo-Martinez, G., Morcillo, S., Gutierrez-Repiso, C., Rubio-Martin, E., Almaraz, M.C., et al. Vitamin D and incidence of diabetes: a prospective cohort study. Clin. Nutr. 31:4 (2012), 571–573.
254. Belenchia, A.M.T.A., Hillman, L.S., Peterson, C.A., Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am. J. Clin. Nutr. 97 (2013), 774–781.
255. Mitri, J., Dawson-Hughes, B., Hu, F.B., Pittas, A.G., Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94:2 (2011), 486–494.
256. Palomer, X., Gonzalez-Clemente, J.M., Blanco-Vaca, F., Mauricio, D., Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes. Metab. 10:3 (2008), 185–197.
257. Amaliev, G., Uchikova, E., Pehlivanov, B., Parahuleva, N., Amaliev, I., The vitamin D deficiency-an independent risk factor for developing preeclampsia. Akush. Ginekol. (Sofiia) 53:8 (2014), 15–17.
258. Singla, R., Gurung, P., Aggarwal, N., Dutta, U., Kochhar, R., Relationship between preeclampsia and vitamin D deficiency: a case control study. Arch. Gynecol. Obstet. 291:6 (2015), 1247–1251.
259. Reeves, I.V., Bamji, Z.D., Rosario, G.B., Lewis, K.M., Young, M.A., Washington, K.N., Vitamin D deficiency in pregnant women of ethnic minority: a potential contributor to preeclampsia. J. Perinatol. 34:10 (2014), 767–773.
260. Behrouz, G.F., Farzaneh, G.S., Leila, J., Jaleh, Z., Eskandar, K.S., Presence of auto-antibody against two placental proteins, annexin A1 and vitamin D binding protein, in sera of women with pre-eclampsia. J. Reprod. Immunol. 99:1–2 (2013), 10–16.
261. Ota, K., Dambaeva, S., Han, A.R., Beaman, K., Gilman-Sachs, A., Kwak-Kim, J., Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity. Hum. Reprod. 29:2 (2014), 208–219.
262. Abedi, P., Mohaghegh, Z., Afshary, P., Latifi, M., The relationship of serum vitamin D with pre-eclampsia in the Iranian women. Matern. Child Nutr. 10:2 (2014), 206–212.
263. Perez-Lopez, F.R., Pasupuleti, V., Mezones-Holguin, E., Benites-Zapata, V.A., Thota, P., Deshpande, A., et al. Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil. Steril. 103:5 (2015), 1278–1288 e4.
264. Karamali, M., Asemi, Z., Ahmadi-Dastjerdi, M., Esmaillzadeh, A., Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial. Public Health Nutr. 19:1 (2016), 156–163.
265. Cannell, J.J., Hollis, B.W., Sorenson, M.B., Taft, T.N., Anderson, J.J., Athletic performance and vitamin D. Med. Sci. Sports Exerc. 41:5 (2009), 1102–1110.
266. Dahlquist, D.T., Dieter, B.P., Koehle, M.S., Plausible ergogenic effects of vitamin D on athletic performance and recovery. J. Int. Soc. Sports Nutr., 12, 2015, 33.
267. Gerster, H., The role of vitamin C in athletic performance. J. Am. Coll. Nutr. 8:6 (1989), 636–643.
268. Hamilton, B., Vitamin D and athletic performance: the potential role of muscle. Asian J. Sports Med. 2:4 (2011), 211–219.
269. Neal, S., Sykes, J., Rigby, M., Hess, B., A review and clinical summary of vitamin D in regard to bone health and athletic performance. Phys. Sportsmed. 43:2 (2015), 161–168.
270. Sharman, I.M., Down, M.G., Norgan, N.G., The effects of vitamin E on physiological function and athletic performance of trained swimmers. J. Sports Med. Phys. Fitness 16:3 (1976), 215–225.
271. Bischoff-Ferrari, H., Vitamin D – from essentiality to functionality. Int. J. Vitam. Nutr. Res. 82:5 (2012), 321–326.
272. Mosekilde, L., Vitamin D requirement and setting recommendation levels: long-term perspectives. Nutr. Rev. 66:10 Suppl 2 (2008), S170–S177.
273. Bischoff, H.A., Borchers, M., Gudat, F., Duermueller, U., Theiler, R., Stahelin, H.B., et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33:1 (2001), 19–24.
274. Bischoff-Ferrari, H.A., Borchers, M., Gudat, F., Durmuller, U., Stahelin, H.B., Dick, W., Vitamin D receptor expression in human muscle tissue decreases with age. J. Bone Miner. Res. 19:2 (2004), 265–269.
275. Lips, P., Binkley, N., Pfeifer, M., Recker, R., Samanta, S., Cohn, D.A., et al. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am. J. Clin. Nutr. 91:4 (2010), 985–991.
276. Holick, M.F., Evidence-based D-bate on health benefits of vitamin D revisited. Dermato-Endocrinology 4:2 (2012), 183–190.
277. Blain, H., Jaussent, A., Thomas, E., Micallef, J.P., Dupuy, A.M., Bernard, P.L., et al. Appendicular skeletal muscle mass is the strongest independent factor associated with femoral neck bone mineral density in adult and older men. Exp. Gerontol. 45:9 (2010), 679–684.
278. Okuno, J., Tomura, S., Yanagi, H., Kim, M.J., Okura, T., Tanaka, K., Evaluation of the association between impaired renal function and physical function among community-dwelling Japanese frail elderly based on the estimated glomerular filtration rate (eGFR). Nihon Ronen Igakkai Zasshi 46:1 (2009), 63–70.
279. Nigil Haroon, N., Anton, A., John, J., Mittal, M., Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: a systematic review of interventional studies. J. Diabetes Metab. Disord., 14, 2015, 3.
280. Bird, M.R., Woodward, M.C., Gibson, E.M., Phyland, D.J., Fonda, D., Asymptomatic swallowing disorders in elderly patients with Parkinson's disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients. Age Ageing 23:3 (1994), 251–254.
281. Heidelbaugh, J.J., Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications. Ther. Adv. Drug Saf. 4:3 (2013), 125–133.
282. Chidlovskii, E., Tahar, A., Deschasse, G., Couturier, P., Wernicke's encephalopathy associated with pellagra encephalopathy: rare and unusual complication in an elderly woman hospitalized for aspiration pneumonia. Rev. Med. Interne 33:8 (2012), 453–456.
283. Marrie, T.J., Pneumonia in the elderly. Curr. Opin. Pulm. Med. 2:3 (1996), 192–197.
284. Dallosso, H.M., McGrother, C.W., Matthews, R.J., Donaldson, M.M., Leicestershire, M.R.C.I.S.G., Nutrient composition of the diet and the development of overactive bladder: a longitudinal study in women. Neurourol. Urodyn. 23:3 (2004), 204–210.
285. Appell, R.A., Sand, P.K., Nocturia: etiology, diagnosis, and treatment. Neurourol. Urodyn. 27:1 (2008), 34–39.
286. Afzal, S., Lange, P., Bojesen, S.E., Freiberg, J.J., Nordestgaard, B.G., Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax 69:1 (2014), 24–31.
287. Zaragoza Buxo, J., Perez, L., Bredy, R., Relation between serum vitamin D level and asthma. Bol. Asoc. Med P. R. 104:2 (2012), 12–16.
288. Sundar, I.K., Rahman, I., Vitamin D and susceptibility of chronic lung diseases: role of epigenetics. Front. Pharmacol., 2, 2011, 50.
289. Morley, J.E., Mooradian, A.D., Silver, A.J., Heber, D., Alfin-Slater, R.B., Nutrition in the elderly. Ann. Intern. Med. 109:11 (1988), 890–904.
290. Millen, A.E., Voland, R., Sondel, S.A., Parekh, N., Horst, R.L., Wallace, R.B., et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch. Ophthalmol. 129:4 (2011), 481–489.
291. Seddon, J.M., Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract. Am. J. Clin. Nutr. 85:1 (2007), 304S–3077S.
292. Shehab, D., Al-Jarallah, K., Mojiminiyi, O.A., Al Mohamedy, H., Abdella, N.A., Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?. Diabet. Med. 29:1 (2012), 43–49.
293. Lv, W.S., Zhao, W.J., Gong, S.L., Fang, D.D., Wang, B., Fu, Z.J., et al. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J. Endocrinol. Invest. 38:5 (2015), 513–518.
294. Anand, P., Terenghi, G., Warner, G., Kopelman, P., Williams-Chestnut, R.E., Sinicropi, D.V., The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2:6 (1996), 703–707.
295. Tague, S.E., Clarke, G.L., Winter, M.K., McCarson, K.E., Wright, D.E., Smith, P.G., Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. J. Neurosci. 31:39 (2011), 13728–13738.
296. Wergeland, S., Torkildsen, O., Myhr, K.M., Aksnes, L., Mork, S.J., Bo, L., Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One, 6(10), 2011, e26262.
297. Bianco, J., Gueye, Y., Marqueste, T., Alluin, O., Risso, J.J., Garcia, S., et al. Vitamin D(3) improves respiratory adjustment to fatigue and H-reflex responses in paraplegic adult rats. Neuroscience 188 (2011), 182–192.
298. Hirani, V., Vitamin D status and pain: analysis from the Health Survey for England among English adults aged 65 years and over. Br. J. Nutr. 107:7 (2012), 1080–1084.
299. Hellweg, R., Wohrle, M., Hartung, H.D., Stracke, H., Hock, C., Federlin, K., Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation. Neurosci. Lett. 125:1 (1991), 1–4.
300. Fukuoka, M., Sakurai, K., Ohta, T., Kiyoki, M., Katayama, I., Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacol. Appl. Skin Physiol. 14:4 (2001), 226–233.
301. Basit, A., Basit, K.A., Fawwad, A., Shaheen, F., Fatima, N., Petropoulos, I.N., et al. Vitamin D for the treatment of painful diabetic neuropathy. BMJ Open Diabetes Res. Care, 4(1), 2016, e000148.
302. Wimalawansa, S.J., Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr. Rev. 17:5 (1996), 533–585.
303. Vandevska-Radunovic, V., Fristad, I., Wimalawansa, S.J., Kvinnsland, I.H., CGRP1 and NK1 receptors in postnatal, developing rat dental tissues. Eur. J. Oral Sci. 111:6 (2003), 497–502.
304. Wimalawansa, S.J., Amylin calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol. 11:2–3 (1997), 167–239.
305. Tague, S., Smith, P.G., Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones. J. Chem. Neuroanat. 41 (2011), 1–12.
306. Fong, C.Y., Kong, A.N., Poh, B.K., Mohamed, A.R., Khoo, T.B., Ng, R.L., et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia 57:8 (2016), 1271–1279.
307. Fong, C.Y., Riney, C.J., Vitamin D deficiency among children with epilepsy in South Queensland. J. Child Neurol. 29:3 (2014), 368–373.
308. Harijan, P., Khan, A., Hussain, N., Vitamin D deficiency in children with epilepsy: do we need to detect and treat it?. J. Pediatr. Neurosci. 8:1 (2013), 5–10.
309. Lee, S.H., Yu, J., Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up. Ann. Pediatr. Endocrinol. Metab. 20:4 (2015), 198–205.
310. Scorza, F.A., Albuquerque, M., Arida, R.M., Terra, V.C., Machado, H.R., Cavalheiro, E.A., Benefits of sunlight: vitamin D deficiency might increase the risk of sudden unexpected death in epilepsy. Med. Hypotheses 74:1 (2010), 158–161.
311. Sonmez, F.M., Donmez, A., Namuslu, M., Canbal, M., Orun, E., Vitamin, D., Deficiency in children with newly diagnosed idiopathic epilepsy. J. Child Neurol. 30:11 (2015), 1428–1432.
312. Zhu, D.M., Liu, Y., Zhang, A.G., Chu, Z.X., Wu, Q., Li, H., et al. High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein. Psychiatry Res. 228:3 (2015), 565–570.
313. Sullivan, S., Wills, A., Lawlor, D., McGrath, J., Zammit, S., Prenatal vitamin D status and risk of psychotic experiences at age 18years-a longitudinal birth cohort. Schizophr. Res. 148:1–3 (2013), 87–92.
314. Itzhaky, D., Amital, D., Gorden, K., Bogomolni, A., Arnson, Y., Amital, H., Low serum vitamin D concentrations in patients with schizophrenia. Isr. Med. Assoc. J. 14:2 (2012), 88–92.
315. Imai, C.M., Halldorsson, T.I., Eiriksdottir, G., Cotch, M.F., Steingrimsdottir, L., Thorsdottir, I., et al. Depression and serum 25-hydroxyvitamin D in older adults living at northern latitudes – AGES-Reykjavik Study. J Nutr Sci., 4, 2015, e37.
316. Gezen-Ak, D., Yilmazer, S., Dursun, E., Why vitamin d in alzheimer's disease? the hypothesis. J. Alzheimers Dis. 40:2 (2014), 257–269.
317. Gezen-Ak, D., Dursun, E., Yilmazer, S., Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurol. Sci. 34:8 (2013), 1453–1458.
318. Cui, X., Groves, N.J., Burne, T.H., Eyles, D.W., McGrath, J.J., Low vitamin D concentration exacerbates adult brain dysfunction. Am J. Clin. Nutr. 97:5 (2013), 907–908.
319. Zhou, Y., Fang, R., Liu, L.H., Chen, S.D., Tang, H.D., Clinical characteristics for the relationship between type-2 diabetes mellitus and cognitive impairment: a cross-sectional study. Aging Dis. 6:4 (2015), 236–244.
320. Morley, J.E., Perry, H.M. 3rd, The management of diabetes mellitus in older individuals. Drugs 41:4 (1991), 548–565.
321. Moore, E.M., Mander, A.G., Ames, D., Kotowicz, M.A., Carne, R.P., Brodaty, H., et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 36:10 (2013), 2981–2987.
322. Suzuki, M., Yoshioka, M., Hashimoto, M., Murakami, M., Noya, M., Takahashi, D., et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am. J. Clin. Nutr. 97:5 (2013), 1004–1013.
323. Afzal, S., Bojesen, S.E., Nordestgaard, B.G., Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia. Alzheimers Dement. 10:3 (2014), 296–302.
324. Annweiler, C., Karras, S.N., Anagnostis, P., Beauchet, O., Vitamin Dsupplements: a novel therapeutic approach for Alzheimer patients. Front. Pharmacol., 5, 2014, 6.
325. Neupane, S.P., Lien, L., Hilberg, T., Bramness, J.G., Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: a cross-sectional study of inpatients in Nepal. Drug Alcohol Depend. 133:2 (2013), 480–485.
326. Rastmanesh, R., Beauchet, O., Annweiler, C., Vitamin D deficiency and depression: causal relationship or artifact?. Biofactors 38:5 (2012), 317–319.
327. Anglin, R.E., Samaan, Z., Walter, S.D., McDonald, S.D., Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br. J. Psychiatry 202 (2013), 100–107.
328. Moy, F.M., Hoe, V.C., Hairi, N.N., Vethakkan, S.R., Bulgiba, A., Vitamin D deficiency and depression among women from an urban community in a tropical country. Public Health Nutr., 2016, 1–7.
329. Mozaffari-Khosravi, H., Nabizade, L., Yassini-Ardakani, S.M., Hadinedoushan, H., Barzegar, K., The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J. Clin. Psychopharmacol. 33:3 (2013), 378–385.
330. Stalpers-Konijnenburg, S.C., Marijnissen, R.M., Gaasbeek, A.B., Oude Voshaar, R.C., Can I have some sunshine to cheer me up? vitamin D deficiency and depression in the elderly. Tijdschr Psychiatr. 53:6 (2011), 365–370.
331. Mellanby, M., Pattison, C.L., The action of Vitamin D in preventing the spread and promoting the arrest of caries in children. Br. Med. J. 2:3545 (1928), 1079–1082.
332. McBeath, E.C., Vitamin D studies, 1933–1934. Am. J. Public Health Nations Health 24:10 (1934), 1028–1030.
333. Hujoel, P.P., Vitamin D and dental caries in controlled clinical trials: systematic review and meta-analysis. Nutr. Rev. 71:2 (2013), 88–97.
334. Alshouibi, E.N., Kaye, E.K., Cabral, H.J., Leone, C.W., Garcia, R.I., Vitamin D and periodontal health in older men. J. Dent. Res. 92:8 (2013), 689–693.
335. Krall, E.A., Wehler, C., Garcia, R.I., Harris, S.S., Dawson-Hughes, B., Calcium and vitamin D supplements reduce tooth loss in the elderly. Am. J. Med. 111:6 (2001), 452–456.
336. Grant, W.B., A review of the role of solar ultraviolet-B irradiance and vitamin D in reducing risk of dental caries. Dermatoendocrinology 3:3 (2011), 193–198.
337. Avenell, A., MacLennan, G.S., Jenkinson, D.J., McPherson, G.C., McDonald, A.M., Pant, P.R., et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J. Clin. Endocrinol. Metab. 97:2 (2012), 614–622.
338. Ensrud, K.E., Blackwell, T.L., Cauley, J.A., Cummings, S.R., Barrett-Connor, E., Dam, T.T., et al. Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J. Am. Geriatr. Soc. 59:1 (2011), 101–106.
339. Ensrud, K.E., Ewing, S.K., Fredman, L., Hochberg, M.C., Cauley, J.A., Hillier, T.A., et al. Circulating 25-hydroxyvitamin D levels and frailty status in older women. J. Clin. Endocrinol. Metab. 95:12 (2010), 5266–5273.
340. Zittermann, A., Iodice, S., Pilz, S., Grant, W.B., Bagnardi, V., Gandini, S., Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 95:1 (2012), 91–100.
341. Dror, Y., Giveon, S.M., Hoshen, M., Feldhamer, I., Balicer, R.D., Feldman, B.S., Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J. Clin. Endocrinol. Metab. 98:5 (2013), 2160–2167.
342. Grant, W.B., Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J. Photochem. Photobiol. B 101:2 (2010), 130–136.
343. Artaza, J.N., Contreras, S., Garcia, L.A., Mehrotra, R., Gibbons, G., Shohet, R., et al. Vitamin D and cardiovascular disease: potential role in health disparities. J. Health Care Poor Underserved 22:4 Suppl (2011), 23–38.
344. Grant, W.B., Wimalawansa, S.J., Holick, M.F., Cannell, J.J., Pludowski, P., Lappe, J.M., et al. Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients 7:3 (2015), 1538–1564.
345. Schottker, B., Saum, K.U., Perna, L., Ordonez-Mena, J.M., Holleczek, B., Brenner, H., Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health?. Eur. J. Epidemiol. 29:3 (2014), 199–210.
346. Whiting, S.J., Calvo, M.S., Dietary recommendations to meet both endocrine and autocrine needs of Vitamin D. J. Steroid Biochem. Mol. Biol. 97:1–2 (2005), 7–12.
347. Manson, J.E., Mayne, S.T., Clinton, S.K., Vitamin D and prevention of cancer–ready for prime time?. N. Engl. J. Med. 364:15 (2011), 1385–1387.
348. Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96:1 (2011), 53–58.
349. Carmel, A.S., Shieh, A., Bang, H., Bockman, R.S., The 25(OH)D level needed to maintain a favorable bisphosphonate response is 33 ng/ml. Osteoporos. Int. 23:10 (2012), 2479–2487.
350. Dawson-Hughes, B., What is the optimal dietary intake of vitamin D for reducing fracture risk?. Calcif. Tissue Int. 92:2 (2013), 184–190.
351. de Koning, L., Henne, D., Hemmelgarn, B.R., Woods, P., Naugler, C., Non-linear relationship between serum 25-hydroxyvitamin D concentration and subsequent hip fracture. Osteoporos. Int. 24:7 (2013), 2061–2065.
352. Okazaki, R., Updates on rickets and osteomalacia: vitamin D deficiency: its pathophysiology and treatment. Clin. Calcium 23:10 (2013), 1483–1489.
353. Ray, D., Goswami, R., Gupta, N., Tomar, N., Singh, N., Sreenivas, V., Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their 25(OH)D and calcium intake rather than vitamin D receptor gene polymorphism. Clin. Endocrinol. (Oxf.) 71:3 (2009), 334–340.
354. Stanbury, S.W., Torkington, P., Lumb, G.A., Adams, P.H., de Silva, P., Taylor, C.M., Asian rickets and osteomalacia: patterns of parathyroid response in vitamin D deficiency. Proc. Nutr. Soc. 34:2 (1975), 111–117.
355. Nurmi, I., Kaukonen, J.P., Luthje, P., Naboulsi, H., Tanninen, S., Kataja, M., et al. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporos. Int. 16:12 (2005), 2018–2024.
356. Mawer, E.B., Davies, M., Vitamin, D., deficiency, rickets and osteomalacia, a returning problem worldwide. Norman, A.W., Bouillon, R., Thomasset, M., (eds.) Vitamin D. Chemistry, Biology and Clinical Applications of the Steroid Hormone, 1997, University of California, California, 899–906.
357. AGS WG. American Geriatrics Society Workgroup on Vitamin D Supplementation for older adults. Recommendations bbstracted from the American Geriatrics Society Consensus Statement on Vitamin D for prevention of falls and their consequences. J. Am. Geriatr. Soc. (2013).
358. Larsen, T., Mose, F.H., Bech, J.N., Hansen, A.B., Pedersen, E.B., Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25:11 (2012), 1215–1222.
359. Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., Esmaillzadeh, A., Effects of calcium plus vitamin D supplementation on anthropometric measurements and blood pressure in Vitamin D insufficient people with type 2 diabetes: a randomized controlled clinical trial. J. Am. Coll. Nutr. 34:4 (2015), 281–289.
360. Anderson, J.L., May, H.T., Horne, B.D., Bair, T.L., Hall, N.L., Carlquist, J.F., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106:7 (2010), 963–968.
361. Perna, L., Schottker, B., Holleczek, B., Brenner, H., Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements. J. Clin. Endocrinol. Metab. 98:12 (2013), 4908–4915.
362. Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., Esmaillzadeh, A., Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57:10 (2014), 2038–2047.
363. Yin, L., Ordonez-Mena, J.M., Chen, T., Schottker, B., Arndt, V., Brenner, H., Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev. Med. 57:6 (2013), 753–764.
364. Schöttker, B.H.U., Schomburg, L., Köhrle, J., Perna, L., Müller, H., Holleczek, B., Brenner, H., Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am. J. Clin. Nutr. 97:4 (2013), 782–793.
365. Porojnicu, A.C., Robsahm, T.E., Dahlback, A., Berg, J.P., Christiani, D., Bruland, O.S., et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?. Lung Cancer 55:3 (2007), 263–270.
366. Tretli, S., Schwartz, G.G., Torjesen, P.A., Robsahm, T.E., Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23:2 (2012), 363–370.
367. Bauer, S.R., Hankinson, S.E., Bertone-Johnson, E.R., Ding, E.L., Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92:3 (2013), 123–131.
368. Mohr, S.B., Garland, C.F., Gorham, E.D., Grant, W.B., Garland, F.C., Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J. 14:3 (2008), 255–260.
369. Science, M., Maguire, J.L., Russell, M.L., Smieja, M., Walter, S.D., Loeb, M., Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin. Infect. Dis. 57:3 (2013), 392–397.
370. Korn, S., Hubner, M., Jung, M., Blettner, M., Buhl, R., Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir. Res., 14, 2013, 25.
371. Checkley, W., Robinson, C.L., Baumann, L.M., Hansel, N.N., Romero, K.M., Pollard, S.L., et al. 25-hydroxy vitamin D levels are associated with childhood asthma in a population-based study in Peru. Clin. Exp. Allergy 45:1 (2015), 273–282.
372. Tangpricha, V., Kelly, A., Stephenson, A., Maguiness, K., Enders, J., Robinson, K.A., et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the cystic fibrosis foundation. J. Clin. Endocrinol. Metab. 97:4 (2012), 1082–1093.
373. Wang, L., Song, Y., Manson, J.E., Pilz, S., Marz, W., Michaelsson, K., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5:6 (2012), 819–829.
374. Pittas, A.G., Nelson, J., Mitri, J., Hillmann, W., Garganta, C., Nathan, D.M., et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 35:3 (2012), 565–573.
375. Tsur, A., Feldman, B.S., Feldhammer, I., Hoshen, M.B., Leibowitz, G., Balicer, R.D., Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care 36:5 (2013), 1361–1367.
376. Khadgawat, R., Thomas, T., Gahlot, M., Tandon, N., Tangpricha, V., Khandelwal, D., et al. The effect of puberty on interaction between Vitamin D status and insulin resistance in obese asian-Indian children. Int. J. Endocrinol., 2012, 2012, 173581.
377. Roth, C.L., Elfers, C., Kratz, M., Hoofnagle, A.N., Vitamin D deficiency in obese children and its relationship to insulin resistance and adipokines. J. Obes., 2011, 2011, 495101.
378. Heaney, R.P., Health is better at serum 25(OH)D above 30 ng/mL. J. Steroid Biochem. Mol. Biol. 136 (2013), 224–228.
379. von Hurst, P.R., Stonehouse, W., Coad, J., Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br. J. Nutr. 103:4 (2010), 549–555.
380. Pacifico, L., Anania, C., Osborn, J.F., Ferraro, F., Bonci, E., Olivero, E., et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur. J. Endocrinol. 165:4 (2011), 603–611.
381. Sabherwal, S., Bravis, V., Devendra, D., Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int. J. Clin. Pract. 64:8 (2010), 1084–1089.
382. Aridi, H.D., Alami, R.S., Fouani, T., Shamseddine, G., Tamim, H., Safadi, B., Prevalence of vitamin D deficiency in adults presenting for bariatric surgery in Lebanon. Surg. Obes. Relat. Dis. 12:2 (2016), 405–411.
383. Censani, M., Stein, E.M., Shane, E., Oberfield, S.E., McMahon, D.J., Lerner, S., et al. Vitamin, D., Deficiency is prevalent in morbidly obese adolescents prior to bariatric surgery. ISRN Obes., 2013, 2013.
384. Ducloux, R., Janin, C., Ducloux, H., Altman, J.J., High vitamin D deficiency rate in metabolic inpatients: is bariatric surgery planning found guilty?. Obes. Surg. 24:11 (2014), 1947–1953.
385. Gemmel, K., Santry, H.P., Prachand, V.N., Alverdy, J.C., Vitamin D deficiency in preoperative bariatric surgery patients. Surg. Obes. Relat. Dis. 5:1 (2009), 54–59.
386. Peterson, L.A., Cheskin, L.J., Schweitzer, M.A., Magnuson, T.H., Steele, K.E., Treatment: for Vitamin D deficiency prior to bariatric surgery: a prospective cohort study. Obes. Surg. 26:5 (2016), 1146–1149.
387. Rothkopf, M.M., Reversible neurologic dysfunction caused by severe vitamin deficiency after malabsorptive bariatric surgery. Surg. Obes. Relat. Dis. 2:6 (2006), 656–660.
388. Slater, G.H., Ren, C.J., Siegel, N., Williams, T., Barr, D., Wolfe, B., et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J. Gastrointest. Surg. 8:1 (2004), 48–55 discussion 4–5.
389. Zeitz, U., Weber, K., Soegiarto, D.W., Wolf, E., Balling, R., Erben, R.G., Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 17:3 (2003), 509–511.
390. Neyestani, T.R., Nikooyeh, B., Alavi-Majd, H., Shariatzadeh, N., Kalayi, A., Tayebinejad, N., et al. Improvement of Vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J. Clin. Endocrinol. Metab., 2012.
391. Chagas, C.E., Borges, M.C., Martini, L.A., Rogero, M.M., Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4:1 (2012), 52–67.
392. Poolsup, N., Suksomboon, N., Plordplong, N., Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis. Diabet. Med. 33:3 (2016), 290–299.
393. Dixon, B.M., Barker, T., McKinnon, T., Cuomo, J., Frei, B., Borregaard, N., et al. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res. Notes, 5, 2012, 575.
394. Holmoy, T., Kampman, M.T., Smolders, J., Vitamin D in multiple sclerosis: implications for assessment and treatment. Expert Rev. Neurother. 12:9 (2012), 1101–1112.
395. Quraishi, M.K., Badsha, H., Rheumatoid arthritis disease activity and vitamin D deficiency in an Asian resident population. Int. J. Rheum. Dis., 2013.
396. Smyk, D.S., Orfanidou, T., Invernizzi, P., Bogdanos, D.P., Lenzi, M., Vitamin D in autoimmune liver disease. Clin. Res. Hepatol. Gastroenterol. 37:5 (2013), 535–545.
397. Quraishi, S.A., Litonjua, A.A., Moromizato, T., Gibbons, F.K., Camargo, C.A. Jr., Giovannucci, E., et al. Association between prehospital vitamin D status and hospital-acquired bloodstream infections. Am. J. Clin. Nutr. 98:4 (2013), 952–959.
398. Nnoaham, K.E., Clarke, A., Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 200837:1 (2016), 113–119.
399. Villar, L.M., Del Campo, J.A., Ranchal, I., Lampe, E., Romero-Gomez, M., Association between vitamin D and hepatitis C virus infection: a meta-analysis. World J. Gastroenterol. 19:35 (2013), 5917–5924.
400. Cacopardo, B., Camma, C., Petta, S., Pinzone, M.R., Cappellani, A., Zanghi, A., et al. Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection. Front. Biosci. (Elite Ed.) 4 (2012), 1276–1286.
401. Slinin, Y., Paudel, M., Taylor, B.C., Ishani, A., Rossom, R., Yaffe, K., et al. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J. Gerontol. A. Biol. Sci. Med. Sci. 67:10 (2012), 1092–1098.
402. Soni, M., Kos, K., Lang, I.A., Jones, K., Melzer, D., Llewellyn, D.J., Vitamin D and cognitive function. Scand. J. Clin. Lab. Invest. Suppl. 243 (2012), 79–82.
403. Holló, A.C.Z., Kamondi, A., Lakatos, P., Szűcs, A., Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav. 202:24 (1) (2016), 131–133.
404. Principi, N., Bianchini, S., Baggi, E., Esposito, S., Implications of maternal vitamin D deficiency for the fetus, the neonate and the young infant. Eur. J. Nutr. 52:3 (2013), 859–867.
405. Bodnar, L.M., Tang, G., Ness, R.B., Harger, G., Roberts, J.M., Periconceptional multivitamin use reduces the risk of preeclampsia. Am. J. Epidemiol. 164:5 (2006), 470–477.
406. Whitehouse, A.J.H.B., Serralha, M., Holt, P.G., Kusel, M.M., Hart, P.H., Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatrics 129:3 (2012), 485–493.
407. Gernand, A.D., Simhan, H.N., Caritis, S., Bodnar, L.M., Maternal vitamin D status and small-for-gestational-age offspring in women at high risk for preeclampsia. Obstet. Gynecol. 123:1 (2014), 40–48.
408. Bodnar, L.M., Simhan, H.N., Catov, J.M., Roberts, J.M., Platt, R.W., Diesel, J.C., et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology 25:2 (2014), 207–214.
409. Schroth, R.J., Jeal, N.S., Kliewer, E., Sellers, E.A., The relationship between vitamin D and severe early childhood caries: a pilot study. Int. J. Vitam. Nutr. Res. 82:1 (2012), 53–62.
410. Mohr, S.B., Garland, F.C., Garland, C.F., Gorham, E.D., Ricordi, C., Is there a role of vitamin D deficiency in type 1 diabetes of children?. Am. J. Prev. Med. 39:2 (2010), 189–190.
411. Mohr, S.B., Garland, C.F., Gorham, E.D., Grant, W.B., Garland, F.C., Ultraviolet B irradiance and vitamin D status are inversely associated with incidence rates of pancreatic cancer worldwide. Pancreas 39:5 (2010), 669–764.
412. Li, H., Stampfer, M.J., Hollis, J.B., Mucci, L.A., Gaziano, J.M., Hunter, D., et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med., 4(3), 2007, e103.
413. Garland, C.F., Gorham, E.D., Mohr, S.B., Grant, W.B., Giovannucci, E.L., Lipkin, M., et al. Vitamin D and prevention of breast cancer: pooled analysis. J. Steroid Biochem. Mol. Biol. 103:3–5 (2007), 708–711.
414. Gorham, E.D., Garland, C.F., Garland, F.C., Grant, W.B., Mohr, S.B., Lipkin, M., et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am. J. Prev. Med. 32:3 (2007), 210–216.
415. Grant, W.B., Garland, C.F., Gorham, E.D., An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results: Cancer Res. 174 (2007), 225–234.
416. Garland, C.F., Gorham, E.D., Baggerly, C.A., Garland, F.C., Re: prospective study of vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst. 100:11 (2008), 826–827.
417. Pludowski, P., Holick, M.F., Pilz, S., Wagner, C.L., Hollis, B.W., Grant, W.B., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 12:10 (2013), 976–989.
418. Singh, S., Furberg, C.D., Calcium supplements increase risk of myocardial infarction. Evid. Based Med., 15(6), 2010, 181.
419. Reid, I.R., Bolland, M.J., Grey, A., Calcium supplements and risk of myocardial infarction: an hypothesis twice tested. Am. J. Med., 125(4), 2012, e15 author reply e7.
420. Bolland, M.J., Avenell, A., Baron, J.A., Grey, A., MacLennan, G.S., Gamble, G.D., et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ, 341, 2010, c3691.
421. Pittas, A.G., Harris, S.S., Stark, P.C., Dawson-Hughes, B., The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30:4 (2007), 980–986.
422. Hennekens, C.H., Barice, E.J., Calcium supplements and risk of myocardial infarction: a hypothesis formulated but not yet adequately tested. Am. J. Med. 124:12 (2011), 1097–1098.
423. Prentice, R.L., Jackson, R.D., Rossouw, J.E., Calcium supplements and cardiovascular risk in the Women's Health Initiative: response to Bolland et al. Osteoporos. Int. 24:8 (2013), 2373–2374.
424. Group, D., Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ, 340, 2010, b5463.
425. Sanders, K.M., Stuart, A.L., Williamson, E.J., Simpson, J.A., Kotowicz, M.A., Young, D., et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:18 (2010), 1815–1822.
426. Sanders, K.M., Stuart, A.L., Williamson, E.J., Jacka, F.N., Dodd, S., Nicholson, G., et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br. J. Psychiatry 198:5 (2011), 357–364.
427. Lyons, R.A., Johansen, A., Brophy, S., Newcombe, R.G., Phillips, C.J., Lervy, B., et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos. Int. 18:6 (2007), 811–818.
428. Law, M., Withers, H., Morris, J., Anderson, F., Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 35:5 (2006), 482–486.